Predictive utility of brief alcohol use disorders identification test (audit) for human immunodeficiency virus antiretroviral medication nonadherence

Substance Abuse

Volumn 32, Issue 4, 2011, Pages 252-261

  Broyles, Lauren Matukaitis ^a   Gordon, Adam J ^a   Sereika, Susan M ^b   Ryan, Christopher M ^b   Erlen, Judith A ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Acquired immunodeficiency syndrome; Alcohol consumption; HIV infection; Mass screening; Patient adherence

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ALCOHOLISM; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT COMPLIANCE; PREDICTIVE VALUE; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; ALCOHOL-RELATED DISORDERS; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 81255146372     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897077.2011.599255     Document Type: Article

References (35)

1. Cook RL, Sereika SM, Hunt SC, Woodward WC, Erlen JA, Conigliaro J. Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med. 2001;16:83-88. (Pubitemid 32183566)
2. Conigliaro J, Gordon AJ, McGinnis KA, Rabeneck L, Justice AC. How harmful is hazardous alcohol use and abuse in HIV infection: Do health care providers know who is at risk? J Acquir Immune Defic Syndr. 2003;33:521-525. (Pubitemid 36886082)
3. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Arch Intern Med. 1998;158:1789-1795. (Pubitemid 28421422)
4. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. Alcohol Use Disorders Identification Test: Guidelines forUse in PrimaryCare. 2nd ed. Geneva:World Health Organization; 2001.
5. Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res. 2007;31:1208-1217. (Pubitemid 46934387)
6. Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. Primary care validation of a single-question alcohol screening test. J Gen Intern Med. 2009;24:783-788.
7. Bradley KA, Kivlahan DR, Williams EC. Brief approaches to alcohol screening: Practical alternatives for primary care. J Gen Intern Med. 2009;24:881-883.
8. Au DH, Kivlahan DR, Bryson CL, Blough D, Bradley KA. Alcohol screening scores and risk of hospitalizations for GI conditions in men. Alcohol Clin Exp Res. 2007;31:443-451. (Pubitemid 46239277)
9. Bradley KA, Rubinsky, AD, Sun H, et al. Alcohol screening and risk of postoperative complications in male VA patients undergoing major non-cardiac surgery. J Gen Int Med. 2010;26:162-169.
10. Bradley KA, Maynard C, Kivlahan DR, McDonell MB, Fihn SD. The relationship between alcohol screening questionnaires and mortality among male veteran outpatients. J Stud Alcohol. 2001;62:826-833. (Pubitemid 34118938)
11. Kinder LS, Bryson CL, Sun H,Williams EC,Bradley KA. Alcohol screening scores and all-cause mortality in male Veterans Affairs patients. J Stud Alcohol Drugs. 2009;70:253-260.
12. Bridevaux IP, Bradley KA, Bryson CL, McDonell MB, Fihn SD. Alcohol screening results in elderly male veterans: Association with health status and mortality. J Am Geriatr Soc. 2004;52:1510-1517. (Pubitemid 39209599)
13. Bryson CL, Au DH, Sun H, Williams EC, Kivlahan DR, Bradley KA. Alcohol screening scores and medication nonadherence. Ann Intern Med. 2008;149:795-804.
14. Pearson CR, Simoni JM, Hoff P, Kurth AE, Martin DP. Assessing antiretroviral adherence via electronic drug monitoring and self-report: An examination of key methodological issues. AIDS Behav. 2007;11:161-173.
15. Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. J Acquir Immune Defic Syndr. 2002;31(S3):S123-S127. (Pubitemid 35453571)
16. Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000;19:124-133.
17. Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: Epidemiology and impact on antiretroviral therapy. Drugs. 2006;66:769-789. (Pubitemid 43765224)
18. Cruess DG, Minor S, Antoni MH, Millon T. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women. J Pers Assess. 2007;89:277-290. (Pubitemid 350274951)
19. Erlen JA, Sereika SM. Fidelity to a 12-week structured medication adherence intervention in patients with HIV. Nurs Res. 2006;55(2 Suppl):S17-S22. (Pubitemid 44620332)
20. Reinert DF, Allen JP. The Alcohol Use Disorders Identification Test: An update of research findings. Alcohol Clin Exp Res. 2007;31:185-199. (Pubitemid 46155217)
21. Gordon AJ, Maisto SA, McNeil M, et al. Three questions can detect hazardous drinkers. J Fam Pract. 2001;50:313-320. (Pubitemid 32295208)
22. Erlen JA, Ch ES, Kim KH, Caruthers D, Sereika, SM. The HIV medication taking self-efficacy scale: Psycometric evaluation. J Adv Nurs. 2010;66:2560-2572.
23. Beck A, Steer RA, Brown GK. BDI-II Manual. San Antonio, TX: The Psychological Corporation, Harcourt Brace & Company; 1996.
24. Costa P, McCrae RR. Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI): Professional Manual. Odessa, FL: Psychological Assessment Resources; 1992.
25. Cohen S, Mermelstein R, Kamarck T, Hoberman H. Measuring the functional components of social support. In: Sarason IG, Sarason BR, eds. Social Support: Theory, Research and Applications. The Hague: Martinus Nijhoff; 1985:73-94.
26. Braithwaite RS, McGinnis KA, Conigliaro J, et al. A temporal and dose-response association between alcoholconsumption and medication adherence among veterans in care. Alcohol Clin Exp Res. 2005;29:1190-1197. (Pubitemid 41060434)
27. Chander G, Lau B, Moore RD. Hazardous alcohol use: A risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr. 2006;43:411-417. (Pubitemid 44737097)
28. Tucker JS, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003;114:573-580. (Pubitemid 36577260)
29. Hopwood CJ, Morey LC, Skodol AE, et al. Fivefactor model personality traits associated with alcoholrelated diagnoses in a clinical sample. J Stud Alcohol Drugs. 2007;68:455-460.
30. O'Cleirigh C, Ironson G,Weiss A, Costa PT Jr. Conscientiousness predicts disease progression (CD4 number and viral load) in people living with HIV. Health Psychol. 2007;26:473-480. (Pubitemid 47454583)
31. Ironson GH, O'Cleirigh C, Weiss A, Schneiderman N, Costa PT Jr. Personality and HIV disease progression: Role of NEO-PI-R openness, extraversion, and profiles of engagement. Psychosom Med. 2008;70:245-253. (Pubitemid 351252973)
32. Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18(Suppl 1):S19-S25. (Pubitemid 38365902)
33. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30. (Pubitemid 30432540)
34. Golin CE, Liu H, HaysRD, et al.Aprospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med. 2002;17:756-765. (Pubitemid 35286241)
35. Galvan FH, Bing EG, Fleishman JA, et al. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: Results from the HIV Cost and Services Utilization Study. J Stud Alcohol. 2002;63:179-186. (Pubitemid 34533593)